Search Results - "Orme, Michelle E"

  • Showing 1 - 12 results of 12
Refine Results
  1. 1

    Systematic review of anti-dsDNA testing for systemic lupus erythematosus: A meta-analysis of the diagnostic test specificity of an anti-dsDNA fluorescence enzyme immunoassay by Orme, Michelle E., Voreck, Anja, Aksouh, Redha, Ramsey-Goldman, Rosalind, Schreurs, Marco W.J.

    Published in Autoimmunity reviews (01-11-2021)
    “…The objective of this meta-analysis was to review the diagnostic performance of anti-dsDNA testing, to determine whether test specificity meets the revised…”
    Get full text
    Journal Article
  2. 2

    Accuracy of component‐resolved diagnostics in peanut allergy: Systematic literature review and meta‐analysis by Nilsson, Caroline, Berthold, Malin, Mascialino, Barbara, Orme, Michelle E, Sjölander, Sigrid, Hamilton, Robert G, Sampson, Hugh

    Published in Pediatric allergy and immunology (01-04-2020)
    “…Background Peanut allergy diagnosis relies on clinical reactivity to peanut supported by detection of specific IgE (sIgE) antibodies. Extract‐based sIgE tests…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Anti-dsDNA Testing Specificity for Systemic Lupus Erythematosus: A Systematic Review by Orme, Michelle E, Voreck, Anja, Aksouh, Redha, Schreurs, Marco W J

    Published in The journal of applied laboratory medicine (05-01-2022)
    “…Autoantibody specificity in autoimmune diseases is variable due to each patient's individual spectrum of autoantibodies and the inherent differences between…”
    Get full text
    Journal Article
  5. 5

    Interventions for the treatment of atrial fibrillation: A systematic literature review and meta-analysis by Sullivan, Sean D, Orme, Michelle E, Morais, Edith, Mitchell, Stephen A

    Published in International journal of cardiology (10-05-2013)
    “…Abstract Background To perform a systematic review/meta-analysis evaluating the efficacy and safety of anti-arrhythmic drugs (AADs) in the treatment of atrial…”
    Get full text
    Journal Article
  6. 6

    A comparative evaluation of gemtuzumab ozogamicin + daunorubicin-cytarabine and other treatments for newly diagnosed acute myeloid leukemia by Ashaye, Ajibade O, Khankhel, Zarmina, Xu, Yingxin, Fahrbach, Kyle, Mokgokong, Ruth, Orme, Michelle E, Lang, Kathryn, Cappelleri, Joseph C, Mamolo, Carla

    Published in Future oncology (London, England) (01-02-2019)
    “…To evaluate the comparative efficacy and safety of gemtuzumab ozogamicin + daunorubicin-cytarabine (GO + DA) versus common induction therapies for newly…”
    Get full text
    Journal Article
  7. 7

    The efficacy and safety of oral anticoagulants in warfarin-suitable patients with nonvalvular atrial fibrillation: systematic review and meta-analysis by Mitchell, Stephen A, Simon, Teresa A, Raza, Syed, Jakouloff, David, Orme, Michelle E, Lockhart, Ian, Drost, Pieter

    Published in Clinical and applied thrombosis/hemostasis (01-11-2013)
    “…The novel oral anticoagulants (NOACs) apixaban, dabigatran, and rivaroxaban have been recently indicated for stroke prevention in patients with atrial…”
    Get more information
    Journal Article
  8. 8

    Comparative effectiveness of glycemic control in patients with type 2 diabetes treated with GLP-1 receptor agonists: a network meta-analysis of placebo-controlled and active-comparator trials by Orme, Michelle E, Nguyen, Hiep, Lu, Jackie Y, Thomas, Susan A

    Published in Diabetes, metabolic syndrome and obesity (01-01-2017)
    “…Clinical studies of patients with type 2 diabetes show that GLP-1 receptor agonists (GLP-1 RAs) improve glycemic control and promote weight loss. We conducted…”
    Get full text
    Journal Article
  9. 9

    Systematic review and network meta-analysis of combination and monotherapy treatments in disease-modifying antirheumatic drug-experienced patients with rheumatoid arthritis : analysis of American College of Rheumatology criteria scores 20, 50, and 70 by Orme, Michelle E

    Published in Biologics (01-01-2012)
    “…Compares the relative efficacy of EU-licensed biologic disease-modifying antirheumatic drug (bDMARD) combination therapy or monotherapy for patients intolerant…”
    Get full text
    Journal Article
  10. 10

    Development of the health and economic consequences of smoking interactive model by Orme, Michelle E, Hogue, Susan L, Kennedy, Lisa M, Paine, Abigail C, Godfrey, Christine

    Published in Tobacco control (01-03-2001)
    “…OBJECTIVE To describe the health and economic consequences of smoking model, a user friendly, web based tool, designed to estimate the health and economic…”
    Get full text
    Journal Article
  11. 11

    The cost effectiveness of tacrolimus versus microemulsified cyclosporin: A 10-year model of Renal transplantation outcomes by ORME, Michelle E, JUREWICZ, Wieslaw A, KUMAR, Nagappan, MCKECHNIE, Tracy L

    Published in PharmacoEconomics (01-01-2003)
    “…In 1983, the launch of cyclosporin was a significant clinical advance for organ transplant recipients. Subsequent drug research led to further advances with…”
    Get full text
    Journal Article
  12. 12

    Cost-effectiveness of the AMOArray multifocal intraocular lens in cataract surgery by Orme, Michelle E, Paine, Abigail C, Teale, Christopher W, Kennedy, Lisa M

    Published in Journal of refractive surgery (1995) (01-03-2002)
    “…To compare the cost and outcomes of bilateral cataract surgery with the foldable AMOArray multifocal intraocular lens (MIOL) versus the foldable monofocal…”
    Get more information
    Journal Article